Bull & Bear

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Watchlist — the structural setup is real but the decisive variable (NIM expansion outrunning credit-cost normalisation) has not yet printed, and a live $897M AT-1 binary sits on the disclosed balance sheet. Bull has the better long-run story: $2.98B of RIDF is mechanically running off into ~9%-yielding advances, CASA is finally outgrowing the industry, cost-to-income fell 460 bps in one year, and SMBC's 20% stake is a regulatory carve-out no peer can replicate. Bear has the better near-term arithmetic: every 25 bps of NIM gain (~$104M) is roughly cancelled by a 25 bps credit-cost mean-reversion off a multi-decade-low 0.2% print, FY26's headline 0.8% ROA collapses to ~0.6% once SR recoveries and provision write-backs are stripped, and management has missed 4-of-4 multi-year strategic targets since FY21. The trade is the slope, not the level — and the slope has to outrun two unhedgeable tails (credit normalisation and the Supreme Court AT-1 verdict). Two consecutive quarters of NIM ≥ 2.9% with credit cost ≤ 0.4% — with no further write-back boost — would resolve this into a Lean Long.

Bull Case

Bull scenario value: ~$0.334 per share (~43% above $0.233). Construction: peer-regression P/B = 0.10 × ROE + 0.7 applied to a forward ROE ~11% → fair P/B 1.8×, on estimated FY27 book value of $0.186. Horizon 12-18 months. Bull's disconfirming signal: retail slippage crossing 4% in any quarter before NIM crosses 3.0% — that combination means credit-cost normalisation has arrived ahead of the spread tailwinds, and the position is exited regardless of valuation.

Bear Case

Bear scenario value: ~$0.146 per share (-37% from $0.233). Construction: P/B compression to ~0.95× as core ROA reverts to 0.5-0.6%, on a book base haircut for a partial AT-1 adverse outcome (clean book $0.170 → partial haircut ~$0.021 → ~$0.149 book × 0.95×). Sell-side median TP is already $0.203 (below current), Emkay at $0.178 on a "Sell" rating. Horizon 12-18 months. Bear's cover signal: NIM exceeding 3.0% AND credit cost holding below 0.4% for two consecutive quarters (Q2 + Q3 FY27) with no further provision write-back boost — that combination would prove NIM expansion is outrunning credit-cost normalisation.

The Real Debate

Verdict

Watchlist. Bull carries more weight on the long-run business case — the RIDF run-off, CASA outperformance, 460 bps of cost-to-income in one year, and the SMBC carve-out are concrete, mechanical, and largely management-independent; this is a real turnaround that has cleared the existential phase. But the single most important tension is whether credit cost mean-reverts before NIM expansion arrives, because the arithmetic is roughly equal-and-opposite — each 25 bps of NIM (~$104M) is approximately offset by 25 bps of credit-cost normalisation off a bottom-of-cycle 0.2% — and Bear is right that the bank has not survived a credit cycle since the rebuild. Bear could still be right if the Supreme Court rules adversely on the $897M AT-1 case (a 16% book haircut no model can hedge) or if the unsecured retail book — already printing $14M card and $17M PL slippages in Q4 FY26 — normalises before NIM crosses 3.0%; sell-side median TP at $0.203 (below current) suggests the consensus already shares some of this concern. The verdict moves to Lean Long on two consecutive quarters (Q2 + Q3 FY27) of NIM ≥ 2.9% AND credit cost ≤ 0.4% AND no further provision write-back boost to net profit — that combination proves the slope is real and not a management aspiration. The verdict moves to Avoid on either an adverse AT-1 ruling or retail slippage crossing 4% before NIM crosses 3%.